Back to today’s briefing

Story perspectives

Ridge Bio Revolutionizes Drug Design with AI and Enzymes

9/12/2025

22 5

Summary

Story summary

Ridge Bio employs cell-free experimentation and machine learning to enhance enzyme and prodrug design.
The company specializes in next-generation bioconjugates, protein design, and enzymatic therapeutics.
Key products include NativeLink enzymes for antibody modifications and ProTrigger linkers for targeted drug activation.
Ridge Bio seeks to create extensive datasets to improve drug design and is expanding partnerships in bioconjugates.

1 of 1

Story summary

Ridge Bio employs cell-free experimentation and machine learning to enhance enzyme and prodrug design.
The company specializes in next-generation bioconjugates, protein design, and enzymatic therapeutics.
Key products include NativeLink enzymes for antibody modifications and ProTrigger linkers for targeted drug activation.
Ridge Bio seeks to create extensive datasets to improve drug design and is expanding partnerships in bioconjugates.